Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Terminated 4Active not recruiting 4Withdrawn 3Unknown 3Recruiting 3Completed 3Not yet recruiting 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 12Gastrointestinal 7Tumor-Agnostic 4Genitourinary 3Thoracic 2Dermatologic 2CNS 2Plasma cell 1Other solid neoplasm 1Other 1Lymphoid 1Head & Neck 1Endocrine 1

Conditions

Hemianopsia 1Glioma 1Brain Neoplasms 1

Interventions

Temozolomide 20Magnetic Resonance Spectroscopy 10Radiotherapy 9Blood Specimen Collection 8pembrolizumab 6Cyclophosphamide 6Bevacizumab 6AZD 6244 6Radiation 5Specimen Handling 4vorasidenib 3fludarabine 3cemiplimab 3aflutinib 3Surgical Procedures, Operative 3Saline Solution 3Radiotherapy, Intensity-Modulated 3Radiosurgery 3Pemetrexed 3Granulocyte-Macrophage Colony-Stimulating Factor 3tislelizumab 2osimertinib 2naxitamab 2gallium maltolate 2fludarabine phosphate 2dinutuximab 2Topotecan 2Standard of Care 2Spinal Puncture 2Receptors, Interleukin-8B 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Standard of Care × CNS × Clear all
NCT07558395 2026-04-30

REVIIH-BT

Institut National de la Santé Et de la Recherche Médicale, France

Phase NA Not yet recruiting
120 enrolled
CNS

Brain Neoplasms, Hemianopsia

NCT07438860 2026-02-27

Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG

Case Comprehensive Cancer Center

Phase 1 Not yet recruiting
12 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡